Stock Analiz

Ionis Pharmaceuticals Inc. (IONS) stock forecast and price target

Price $29.06 · data as of November 13, 2026

12-month price target

Average target$68.48
Upside / downside+135.6%
Analysts23
ConsensusBuy
Low $41.00Average $68.48High $105.00

Gold marker: average target · white marker: today’s price ($29.06)

Analyst ratings

Strong buy 8Buy 13Hold 4Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-2.42−56.9%$920M
Next fiscal year
ends December 31, 2027
$-2.03+16.4%$1.2B
Next quarter
ends December 31, 2026
$-0.93+18.6%$182M
Quarter after
ends December 31, 2026
$-0.85+26.2%$217M

Consensus of the analysts covering Ionis Pharmaceuticals, updated daily. In the last 30 days 1 estimates were raised and 0 lowered.

Frequently asked questions

What is the Ionis Pharmaceuticals stock price target?

The average 12-month target from 23 analysts is $68.48, 135.6% above the current price of $29.06 Targets range from $41.00 to $105.00.

Is Ionis Pharmaceuticals a buy according to analysts?

The consensus rating is “Buy” (8 strong buy, 13 buy, 4 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is Ionis Pharmaceuticals expected to earn?

Analysts expect EPS of $-2.42 for the fiscal year ending December 31, 2026 and $-2.03 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.